Aplastic anemia
Keywords:
-Abstract
-
Downloads
References
Montane E, Ibanez L, Vidal X, Ballarin E, Puig R, Garcia N, et al. Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica. 2008;93:518-23.
Bessler M, Mason P, Link D, Wilson D. Inherited bone marrrow failure syndromes. In: DGN, SHO, DG, et al., editors. Nathans and Oski’s Hematology of infancy and childhood. 8. Philadelphia: W. B. Saunders Co; 2014. p.182-253.
Marsh J CW, Ball SE, Cavenagh J, Darbyshire P, Dokal I, Gordon-Smith EC, et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009;147:43-70.
Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, et al. Guideline for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016;172:187-207.
West AH, Churpek JE. Old and new tolls in the clinical diagnosis of inherited bone marrow failure syndromes. Hematology Am Soc Hematol Educ Program. 2017;1:79-87.
Dufour C, Ferretti E, Bagnasco F, Burlando O, Lanciotti M, Ramenghi U, et al. Changes in cytokine profile pre- and postimmunosuppression in acquired aplastic anemia. Haematologica. 2009;94:1743-7.
Young NS, Scheiberg P, Calado RT. Aplastic anemia. Curr Opin Hematol. 2008;15:162-8.
Schrezenmeier H, Bacigalupo A. Aplastic anemia - pathophysiology and treatment. Cambridge: Cambridge University Press; 2000.
Young N, Calado RT, Scheiberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108:2509-19.
Baumann I, Fuhrer M, Behrendt S, Campr V, Csomor J, Furlan I, et al. Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria. Histopathology. 2012;61:10-7.
Montane E, Ibanez L, Vidal X, Ballarin E, Puig R, Garcia N, et al. Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica. 2008;93:518-23.
Bacigalupo A. How I treat acquired aplastic anemia. Blood 2017;129:1428-36.
Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu CO, et al. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med. 2011;365:430-8.
Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, et al. Eltrombopag added to standard immunosuppression for aplastic anemia. N Engl J Med. 2017;376:1540-50.
Scheinberg P, Young NS. How I treat acquired aplastic anemia. Blood. 2012;120:1185-96.
Scheinberg P, Nunez O, Young NS. Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia. Br J Haematol. 2006;133;622-7
Di Bona E, Rodeghiero F, Bruno B, Gabbas A, Foa P, Locasciulli A, et al. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto
di Midllo Osseo (GITMO). Br J Haematol. 1999;107:330-4.
Gardner FH, Juneja HS. Androstane therapy to treat aplastic anaemia in adults: an uncontrolled pilot study. Br J Haematol. 1987;65:295-300.
French Cooperative Group for the Study of Aplastic and Refractory Anemias. Androgen therapy in aplastic anaemia: a comparative study of high and low-doses and of 4 different androgens. Scand J Haematol. 1986;36:346-52.
Olnes MJ, Scheinberg P, Calvo KR, Desmond R, Tang Y, Dumitriu B, et al. Elthrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med. 2012;367:11-9.
Marsh J, Schrezenmeier H, Marin P, Ilhan O, Ljungman P, McCann S, et al. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin
and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood. 1999;93:2191-5.
